Literature DB >> 7527758

Rational therapy of eating disorders.

S J Crow1, J E Mitchell.   

Abstract

Pharmacological treatments are one of several strategies used in the treatment of anorexia nervosa and bulimia nervosa. Many studies have found that antidepressants are effective in the treatment of bulimia nervosa and these drugs represent a mainstay of treatment for these patients. Over the past several years, selective serotonin reuptake inhibitors have become perhaps the most commonly used class of drugs. A variety of medications have been investigated for anorexia nervosa, but there is little consistent evidence that medications are effective. In both these illnesses it is important to diagnose and treat any comorbid conditions including mood and anxiety disorders; this may involve the administration of other medications, including anxiolytics such as benzodiazepines or buspirone or mood stabilising agents such as lithium, valproic acid (valproate sodium) or carbamazepine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527758     DOI: 10.2165/00003495-199448030-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  36 in total

1.  Primary anorexia nervosa (weight phobia) in males.

Authors:  M K Hasan; R W Tibbetts
Journal:  Postgrad Med J       Date:  1977-03       Impact factor: 2.401

2.  The effect of cyproheptadine on hunger, calorie intake and body weight in man.

Authors:  T Silverstone; D Schuyler
Journal:  Psychopharmacologia       Date:  1975

3.  Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin.

Authors:  E J Sabine; A Yonace; A J Farrington; K H Barratt; A Wakeling
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

4.  Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy.

Authors:  M M Fichter; K Leibl; W Rief; E Brunner; S Schmidt-Auberger; R R Engel
Journal:  Pharmacopsychiatry       Date:  1991-01       Impact factor: 5.788

5.  A placebo-controlled, double-blind trial of amitriptyline in bulimia.

Authors:  J E Mitchell; R Groat
Journal:  J Clin Psychopharmacol       Date:  1984-08       Impact factor: 3.153

6.  Naloxone but not CCK-8 may attenuate binge-eating behavior in patients with the bulimia syndrome.

Authors:  J E Mitchell; D E Laine; J E Morley; A S Levine
Journal:  Biol Psychiatry       Date:  1986-12       Impact factor: 13.382

7.  Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study.

Authors:  J Biederman; D B Herzog; T M Rivinus; G P Harper; R A Ferber; J F Rosenbaum; J S Harmatz; R Tondorf; P J Orsulak; J J Schildkraut
Journal:  J Clin Psychopharmacol       Date:  1985-02       Impact factor: 3.153

8.  Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride.

Authors:  G Stacher; T A Abatzi-Wenzel; S Wiesnagrotzki; H Bergmann; C Schneider; G Gaupmann
Journal:  Br J Psychiatry       Date:  1993-03       Impact factor: 9.319

9.  Treatment of bulimia with desipramine: a double-blind crossover study.

Authors:  J Barlow; J Blouin; A Blouin; E Perez
Journal:  Can J Psychiatry       Date:  1988-03       Impact factor: 4.356

10.  A double-blind controlled trial of lithium carbonate primary anorexia nervosa.

Authors:  H A Gross; M H Ebert; V B Faden; S C Goldberg; L E Nee; W H Kaye
Journal:  J Clin Psychopharmacol       Date:  1981-11       Impact factor: 3.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.